Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1380 participants.
Also called NCT06157502
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 1,380 participants
- Sponsor
- Registry
-
NCT06157502
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06157502. Randomized; triple masking; primary purpose treatment. Start 2024-01-11 (actual); primary completion 2025-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY)
- Condition
- Ischemic Stroke, Acute
- Intervention (Drug)
- Shuxuening Injection
- Intervention (Other)
- Placebo
- Lead sponsor
- Beijing Tiantan Hospital
Record details
- Record id
cardio:ct-nct06157502- Content hash
995c9f73d5f01590bb93a8c581d8f50025ec2c89c57188b6d17eea5e5e155705